CN Stock MarketDetailed Quotes
600276 Jiangsu Hengrui Pharmaceuticals
- 46.39
- +0.78+1.71%
Trading Apr 29 10:50 CST
295.92BMarket Cap66.75P/E (TTM)
46.43High45.53Low144.01KlotVolume45.60Open45.61Pre Close663.18MTurnover0.23%Turnover Ratio68.83P/E (Static)6.38BShares50.5052wk High7.07P/B295.92BFloat Cap35.5152wk Low50.17Limit Up6.38BShs Float96.90Historical High41.05Limit Down1.97%Amplitude-0.75Historical Low0.16Dividend TTM46.05Avg Price56.18KlotAsk0.34%Div YieldTTM100Lot Size79.49KlotBid
Jiangsu Hengrui Pharmaceuticals Key Stats
All
YOY
| (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 38.44%5B | 29.76%24.09B | 3.73%15.68B | 26.87%11.51B | -21.40%3.61B | -25.80%18.57B | -22.93%15.12B | -27.56%9.07B | -35.00%4.59B | 3.59%25.02B |
| Refunds of taxes and levies | 28.07%5.23M | -74.78%65.62M | -79.39%43.74M | -85.08%30.04M | -95.13%4.09M | 55.36%260.23M | 415.22%212.21M | 388.73%201.3M | --83.89M | 23,373.17%167.5M |
| Cash received relating to other operating activities | 181.50%1.13B | 78.12%1.3B | 60.96%728.8M | 98.04%606.88M | 143.21%402.2M | 49.90%727.34M | 103.69%452.79M | 175.04%306.45M | 57.62%165.38M | 27.70%485.23M |
| Cash inflows from operating activities | 52.76%6.14B | 30.17%25.46B | 4.26%16.46B | 26.80%12.15B | -17.05%4.02B | -23.84%19.56B | -20.61%15.78B | -24.42%9.58B | -32.47%4.84B | 4.65%25.68B |
| Goods services cash paid | 90.15%318.17M | 9.62%1.18B | 21.54%837.5M | 37.83%743.71M | -54.61%167.32M | 4.57%1.07B | -8.96%689.08M | 29.55%539.6M | 5.83%368.65M | -10.58%1.03B |
| Staff behalf paid | 5.96%1.53B | -7.73%5.75B | -2.82%4.41B | -5.81%3.02B | -7.21%1.45B | -12.75%6.23B | -12.36%4.54B | -8.28%3.21B | -20.67%1.56B | 26.94%7.14B |
| All taxes paid | 91.16%467.8M | -13.64%1.63B | -13.12%1.07B | -8.85%923.73M | -12.55%244.72M | 6.56%1.89B | -10.65%1.23B | -20.32%1.01B | -52.52%279.84M | -41.28%1.77B |
| Cash paid relating to other operating activities | 31.79%2.56B | 1.74%9.25B | -18.34%5.83B | 15.32%4.58B | -21.82%1.94B | -21.03%9.09B | -21.31%7.14B | -33.69%3.97B | -38.87%2.49B | 1.82%11.51B |
| Cash outflows from operating activities | 28.36%4.88B | -2.62%17.81B | -10.66%12.15B | 6.15%9.27B | -18.99%3.8B | -14.76%18.29B | -17.01%13.6B | -21.86%8.73B | -32.66%4.69B | 1.67%21.46B |
| Net cash flows from operating activities | 486.35%1.25B | 504.12%7.64B | 96.97%4.31B | 240.11%2.88B | 44.52%213.97M | -70.01%1.27B | -37.47%2.19B | -43.57%845.42M | -25.71%148.06M | 22.93%4.22B |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | -72.85%2.61B | -70.88%2.51B | -63.89%1.91B | -70.68%1.01B | -31.63%9.6B | -10.86%8.61B | -36.20%5.29B | -46.31%3.44B | -52.62%14.04B |
| Cash received from returns on investments | -73.86%9.01M | -42.64%95.51M | -30.66%89.49M | 31.37%70.39M | 16.14%34.47M | -35.91%166.49M | -23.20%129.07M | -47.54%53.58M | -41.14%29.68M | -23.92%259.77M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -38.07%1.62M | -0.14%20.18M | -18.64%13.23M | -70.60%4.36M | 360.45%2.62M | 25.44%20.21M | 3.57%16.26M | -2.12%14.83M | -17.37%568.79K | 353.09%16.11M |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | --36.05M | --36.05M | --36.05M | ---- | ---- |
| Cash inflows from investing activities | -98.98%10.63M | -72.28%2.72B | -70.32%2.61B | -63.20%1.99B | -69.87%1.05B | -31.39%9.83B | -10.68%8.79B | -35.85%5.4B | -46.26%3.47B | -52.25%14.32B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 45.80%561.02M | -25.52%1.48B | -10.70%1.37B | -33.39%985.28M | -45.01%384.79M | 19.68%1.99B | 15.45%1.53B | 104.89%1.48B | 134.13%699.79M | 200.30%1.66B |
| Cash paid to acquire investments | 9,601.63%200M | -99.77%17.09M | -99.96%2.17M | -99.96%2.17M | -99.91%2.06M | -43.63%7.44B | -28.38%5.7B | -25.80%5.08B | -49.49%2.41B | -52.23%13.2B |
| Cash outflows from investing activities | 96.72%761.02M | -84.09%1.5B | -81.04%1.37B | -84.95%987.44M | -87.55%386.85M | -36.54%9.43B | -22.11%7.24B | -13.34%6.56B | -38.65%3.11B | -47.27%14.87B |
| Net cash flows from investing activities | -213.71%-750.39M | 213.18%1.22B | -20.39%1.24B | 185.65%998.21M | 79.72%659.93M | 171.45%390.29M | 181.93%1.55B | -238.72%-1.17B | -73.78%367.2M | -130.38%-546.26M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | -97.50%750.47K | ---- | 10.78%378.86M | -85.57%45.59M | -90.51%30M | ---- | -74.10%342M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | ---- | ---- | 10.78%378.86M | -85.57%45.59M | -90.51%30M | ---- | 129.37%342M |
| Cash from borrowing | ---- | -98.33%21.1M | --21.1M | --10M | --10M | --1.26B | ---- | ---- | ---- | ---- |
| Cash received relating to other financing activities | ---- | ---- | ---- | ---- | ---- | --159.99M | --541.95M | --541.95M | ---- | ---- |
| Cash inflows from financing activities | ---- | -98.83%21.1M | -96.41%21.1M | -98.12%10.75M | --10M | 425.98%1.8B | 85.93%587.54M | 81.00%571.95M | ---- | -74.10%342M |
| Borrowing repayment | ---- | --1.28B | --1.27B | --1.26B | --1.26B | ---- | ---- | ---- | ---- | ---- |
| Dividend interest payment | ---- | 0.72%1.02B | 2.29%1.02B | --983.48M | --2.6M | -4.76%1.02B | -6.23%999.79M | ---- | ---- | 4.83%1.07B |
| Cash payments relating to other financing activities | -91.45%18.13M | -21.82%861.6M | -28.31%823.38M | -27.79%389.08M | -57.86%212.2M | 302.11%1.1B | 12,430.44%1.15B | 5,777.88%538.79M | --503.59M | 2,188.38%274.08M |
| Cash outflows from financing activities | -98.77%18.13M | 49.48%3.17B | 44.81%3.11B | 388.61%2.63B | 192.86%1.47B | 57.99%2.12B | 99.77%2.15B | -49.90%538.79M | --503.59M | 30.24%1.34B |
| Net cash flows from financing activities | 98.76%-18.13M | -886.42%-3.14B | -97.97%-3.09B | -8,004.86%-2.62B | -190.87%-1.46B | 68.07%-318.77M | -105.53%-1.56B | 104.37%33.17M | ---503.59M | -442.84%-998.32M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -81.38%-18.21M | -84.43%12.53M | -77.30%19.7M | -31.32%27.7M | -115.72%-10.04M | 577.26%80.5M | 9,994.90%86.75M | 600.60%40.34M | -226.55%-4.65M | 81.07%-16.87M |
| Net increase in cash and cash equivalents | 177.85%467.87M | 304.58%5.73B | 9.18%2.48B | 618.90%1.28B | -8,672.93%-600.95M | -46.67%1.42B | -31.05%2.27B | -115.70%-246.57M | -99.56%7.01M | -51.08%2.66B |
| Add:Begin period cash and cash equivalents | 39.44%20.27B | 10.80%14.54B | 10.80%14.54B | 10.80%14.54B | 10.80%14.54B | 25.40%13.12B | 25.40%13.12B | 25.40%13.12B | 25.40%13.12B | 107.97%10.46B |
| End period cash equivalent | 48.81%20.74B | 39.44%20.27B | 10.56%17.01B | 22.86%15.82B | 6.17%13.94B | 10.80%14.54B | 11.90%15.39B | 6.98%12.87B | 8.84%13.13B | 25.40%13.12B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Suya Jincheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Suya Jincheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Suya Jincheng Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
%Chg